These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 969999)
1. [Behavior of heparinocytes and of fibrinolytic degradation products after discontinuation of hormonal contraceptives]. Frick G; Göretzlehner G; Frick U Zentralbl Gynakol; 1976; 98(15):908-13. PubMed ID: 969999 [TBL] [Abstract][Full Text] [Related]
2. [Demonstration of fibrinolytic split products during administration of hormonal contraceptives]. Frick G; Göretzlehner G; Frick U Zentralbl Gynakol; 1975; 97(16):1001-7. PubMed ID: 1199513 [TBL] [Abstract][Full Text] [Related]
3. Relations between fibrinogen degradation products and heparinocytes. Frick G; Frick U Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):271-6. PubMed ID: 61922 [TBL] [Abstract][Full Text] [Related]
4. [Changes in heparinocytes during the administration of Depositon and Sequenz-Ovosiston]. Frick G; Göretzlehner G Zentralbl Gynakol; 1975; 97(8):488-93. PubMed ID: 56830 [TBL] [Abstract][Full Text] [Related]
5. [Hormonal contraception--side effects and surgical aspects (author's transl)]. Göretzlehner G; Carol W; Köhler G Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744 [TBL] [Abstract][Full Text] [Related]
6. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis. Hedlin AM Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426 [TBL] [Abstract][Full Text] [Related]
9. [Effects and side effects of hormonal contraceptives]. Carol W; Göretzlehner G Z Arztl Fortbild (Jena); 1980 Feb; 74(3):97-104. PubMed ID: 7415248 [TBL] [Abstract][Full Text] [Related]
11. [Significance of hormonal contraceptives for coronary heart disease]. Gohlke-Bärwolf C Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662 [TBL] [Abstract][Full Text] [Related]
12. [Contraception in preclimacteric women with special regard to oral contraceptives (author's transl)]. Salzer H; Schneider WH; Eppel W Wien Med Wochenschr; 1980 Mar; 130(6):218-21. PubMed ID: 7395249 [TBL] [Abstract][Full Text] [Related]
13. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception. Vooijs GP; van der Graaf Y; Elias AG Acta Cytol; 1987; 31(4):417-26. PubMed ID: 3604536 [TBL] [Abstract][Full Text] [Related]
14. [Menstrual and child-bearing functions of women using mechanical and hormonal contraceptives]. Shinkareva LF; Nagovitsina AI; Zhdanova VI Vopr Okhr Materin Det; 1976 Oct; 21(10):72-5. PubMed ID: 997312 [TBL] [Abstract][Full Text] [Related]
15. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases]. Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001 [TBL] [Abstract][Full Text] [Related]
16. [Advantages and risks of hormonal contraception]. Mall-Haefeli M Fortschr Med; 1982 Apr; 100(16):723-8. PubMed ID: 7084860 [TBL] [Abstract][Full Text] [Related]